Chiron Real Estate Inc.
XRNNYSE
$37.74
↓ -0.4%Jul 17 close · end-of-day
Price
1Y↑ +13.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$499.5M
Enterprise Value
$491.3M
P/E
—
P/S
3.3
P/B
1.0
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$151.7M
Net Income (TTM)
—
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
—
ROIC
—
Debt / Equity
—
Net Cash
$8.2M
Return 1Y
+13.6%
Company profile
Global Medical REIT is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
- CEO
- Jeffrey M. Busch
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Trading
- Employees
- 30
- Headquarters
- Maryland
- Website
- globalmedicalreit.com
Earnings
XRN Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$38.1M↑ +10.0%
Diluted EPS-$0.06↓ -137.5%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $93.7M | $115.9M | $137.3M | $141.0M | $138.8M | $148.2M |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | -$2.5M | $18.3M | $20.0M | $21.7M | $6.7M | -$6.9M |
| Diluted EPS | -$0.17 | $0.19 | $0.20 | $1.13 | $0.06 | -$0.91 |
| Operating cash flow | $34.5M | $69.0M | $76.5M | $68.4M | $70.0M | $73.6M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | -2.7% | 15.8% | 14.6% | 15.4% | 4.8% | -4.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.2M | $34.3M | $35.2M | $34.6M | $38.0M | $37.2M | $38.4M | $38.1M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | — | — | — | — | — | — | — | — |
| Diluted EPS | -$0.05 | $0.14 | -$0.04 | $0.16 | -$0.01 | -$0.45 | -$0.61 | -$0.06 |
| Operating cash flow | $18.9M | $16.3M | $20.5M | $12.3M | $22.1M | $17.6M | $21.6M | $13.4M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Jul 14, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.